Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on September 1, 2026

Sep. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Ero to Host 2026 Capital Markets Day

Indeterminate GlobeNewswire

Sep. 1, 2026

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Indeterminate GlobeNewswire

Sep. 1, 2026

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis annonce sa participation à plusieurs conférences investisseurs

Indeterminate GlobeNewswire

Sep. 1, 2026

Cellectis Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Sana Biotechnology to Present at September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Cytek Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

CAMP4 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Indeterminate GlobeNewswire

Sep. 1, 2026

Astera Labs to Participate in the Citi 2026 Global TMT Conference

Indeterminate GlobeNewswire